A carregar...
Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
Hydroxychloroquine (HCQ) has been proposed in the treatment of SARS-coronavirus 2 (SARS-CoV-2) infection, albeit with much controversy. In vitro, HCQ effectively inhibits viral entry, but its use in the clinic has been hampered by conflicting results. A better understanding of HCQ’s mechanism of act...
Na minha lista:
| Publicado no: | bioRxiv |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cold Spring Harbor Laboratory
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7430563/ https://ncbi.nlm.nih.gov/pubmed/32817933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.13.250217 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|